+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A Photoactivatable Botulinum Neurotoxin for Inducible Control of Neurotransmission



A Photoactivatable Botulinum Neurotoxin for Inducible Control of Neurotransmission



Neuron 2019



Regulated secretion is critical for diverse biological processes ranging from immune and endocrine signaling to synaptic transmission. Botulinum and tetanus neurotoxins, which specifically proteolyze vesicle fusion proteins involved in regulated secretion, have been widely used as experimental tools to block these processes. Genetic expression of these toxins in the nervous system has been a powerful approach for disrupting neurotransmitter release within defined circuitry, but their current utility in the brain and elsewhere remains limited by lack of spatial and temporal control. Here we engineered botulinum neurotoxin B so that it can be activated with blue light. We demonstrate the utility of this approach for inducibly disrupting excitatory neurotransmission, providing a first-in-class optogenetic tool for persistent, light-triggered synaptic inhibition. In addition to blocking neurotransmitter release, this approach will have broad utility for conditionally disrupting regulated secretion of diverse bioactive molecules, including neuropeptides, neuromodulators, hormones, and immune molecules.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446967

Download citation: RISBibTeXText

PMID: 30704911

DOI: 10.1016/j.neuron.2019.01.002


Related references

Botulinum neurotoxin A blocks cholinergic ganglionic neurotransmission in the dog heart. Japanese Journal of Pharmacology 89(3): 249-254, 2002

Botulinum neurotoxin A impairs neurotransmission following retrograde transynaptic transport. Traffic 13(8): 1083-1089, 2012

Botulinum neurotoxin A BoNT/A impairs neurotransmission following retrograde transynaptic transport. 2012

Cross-reactive MAb to the binding domains of botulinum neurotoxin A, B, and E developed using a sequential immunization strategy: Anti-botulinum neurotoxin. Hybridoma 26(6): 435-436, 2007

Preclinical update on BOTOX(R) (botulinum toxin type A)-purified neurotoxin complex relative to other botulinum neurotoxin preparations. European Journal of Neurology 6(Suppl. 4): S3-S10, 1999

Analysis of neurotoxin cluster genes in Clostridium botulinum strains producing botulinum neurotoxin serotype A subtypes. Applied and Environmental Microbiology 74(9): 2778-2786, 2008

In vitro and ex vivo screening of candidate therapeutics to restore neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A1. Toxicon 147: 47-53, 2017

Genomic sequences of six botulinum neurotoxin-producing strains representing three clostridial species illustrate the mobility and diversity of botulinum neurotoxin genes. Infection, Genetics and Evolution 30: 102-113, 2015

Development of MAb to the binding domains of botulinum neurotoxin B or E using a sequential immunization strategy: Anti-botulinum neurotoxin. Hybridoma 26(6): 437-438, 2007

Superactivation of the botulinum neurotoxin serotype A light chain metalloprotease: a new wrinkle in botulinum neurotoxin. Journal of the American Chemical Society 128(13): 4176-4177, 2006

Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin. Toxins 8(5), 2017

Dual effects of 3,4-Diaminopyridine on neurotransmission in diaphragmatic motor nerve terminals poisoned by botulinum neurotoxin: Understanding clinical efficacy. Toxicon 123: S7-S8, 2016

Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge. Vaccine 29(28): 4638-4645, 2011

PCR for detection of botulinum neurotoxin genes in botulinum neurotoxin A-,B-,E-,F- and G- producing Clostridia. Zhonghua Weishengwuxue He Mianyixue Zazhi 17(3): 182-184, 1997

Molecular cloning of the gene encoding the mosaic neurotoxin, composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms. Applied and Environmental Microbiology 62(2): 662-667, 1996